Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology

Gaetano Aurilio; Stefania Gori; Franco Noie; Giancarlo Pruned; Francesca Coati; Valter Torri; Gianluigi Lunardi; Francesco Atzori; Nicla La Verde; Giuseppe Luigi Banna; A. Rossi; Lucia Del Mastro; Francesca Di Fabio; Maria Marcon; V. Gebbia; Fotios Loupakis; Laura Orlando; Libero Ciuffreda; Placido Amadio; Gabriele Luppi; Stefania Redana; G. Filippelli; Anna Lisa Gentile; Elena Collovà

doi:10.5301/tj.5000383

Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology

Gaetano Aurilio, Stefania Gori, Franco Noie, Giancarlo Pruned, Francesca Coati, Valter Torri, Gianluigi Lunardi, Francesco Atzori, Nicla La Verde, Giuseppe Luigi Banna, A. Rossi, Lucia Del Mastro, Francesca Di Fabio, Maria Marcon, V. Gebbia, Fotios Loupakis, Laura Orlando, Libero Ciuffreda, Placido Amadio, Gabriele LuppiStefania Redana, G. Filippelli, Anna Lisa Gentile, Elena Collovà

Research output: Contribution to journal › Article › peer-review

Abstract

Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ² test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p

Original language	English
Pages (from-to)	108-113
Number of pages	6
Journal	Tumori
Volume	102
Issue number	1
DOIs	https://doi.org/10.5301/tj.5000383
Publication status	Published - Jan 1 2016

Keywords

IV chemotherapy
Oral chemotherapy
Patient perspective
Questionnaire
Treatment

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.5301/tj.5000383

Cite this

Aurilio, G., Gori, S., Noie, F., Pruned, G., Coati, F., Torri, V., Lunardi, G., Atzori, F., La Verde, N., Banna, G. L., Rossi, A., Del Mastro, L., Di Fabio, F., Marcon, M., Gebbia, V., Loupakis, F., Orlando, L., Ciuffreda, L., Amadio, P., ... Collovà, E. (2016). Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology. Tumori, 102(1), 108-113. https://doi.org/10.5301/tj.5000383

Aurilio, G, Gori, S, Noie, F, Pruned, G, Coati, F, Torri, V, Lunardi, G, Atzori, F, La Verde, N, Banna, GL, Rossi, A, Del Mastro, L, Di Fabio, F, Marcon, M, Gebbia, V, Loupakis, F, Orlando, L, Ciuffreda, L, Amadio, P, Luppi, G, Redana, S, Filippelli, G, Gentile, AL & Collovà, E 2016, 'Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology', Tumori, vol. 102, no. 1, pp. 108-113. https://doi.org/10.5301/tj.5000383

@article{7d1dbfb9c19945d4a82518d38dc17a5a,

title = "Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology",

abstract = "Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p",

keywords = "IV chemotherapy, Oral chemotherapy, Patient perspective, Questionnaire, Treatment",

author = "Gaetano Aurilio and Stefania Gori and Franco Noie and Giancarlo Pruned and Francesca Coati and Valter Torri and Gianluigi Lunardi and Francesco Atzori and {La Verde}, Nicla and Banna, {Giuseppe Luigi} and A. Rossi and {Del Mastro}, Lucia and {Di Fabio}, Francesca and Maria Marcon and V. Gebbia and Fotios Loupakis and Laura Orlando and Libero Ciuffreda and Placido Amadio and Gabriele Luppi and Stefania Redana and G. Filippelli and Gentile, {Anna Lisa} and Elena Collov{\`a}",

year = "2016",

month = jan,

day = "1",

doi = "10.5301/tj.5000383",

language = "English",

volume = "102",

pages = "108--113",

journal = "Tumori",

issn = "0300-8916",

publisher = "SAGE Publications Ltd",

number = "1",

}

TY - JOUR

T1 - Oral chemotherapy and patient perspective in solid tumors

T2 - A national survey by the Italian association of medical oncology

AU - Aurilio, Gaetano

AU - Gori, Stefania

AU - Noie, Franco

AU - Pruned, Giancarlo

AU - Coati, Francesca

AU - Torri, Valter

AU - Lunardi, Gianluigi

AU - Atzori, Francesco

AU - La Verde, Nicla

AU - Banna, Giuseppe Luigi

AU - Rossi, A.

AU - Del Mastro, Lucia

AU - Di Fabio, Francesca

AU - Marcon, Maria

AU - Gebbia, V.

AU - Loupakis, Fotios

AU - Orlando, Laura

AU - Ciuffreda, Libero

AU - Amadio, Placido

AU - Luppi, Gabriele

AU - Redana, Stefania

AU - Filippelli, G.

AU - Gentile, Anna Lisa

AU - Collovà, Elena

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p

AB - Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p

KW - IV chemotherapy

KW - Oral chemotherapy

KW - Patient perspective

KW - Questionnaire

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84962833468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962833468&partnerID=8YFLogxK

U2 - 10.5301/tj.5000383

DO - 10.5301/tj.5000383

M3 - Article

VL - 102

SP - 108

EP - 113

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 1

ER -

Oral chemotherapy and patient perspective in solid tumors: A national survey by the Italian association of medical oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this